{"id":68921,"date":"2024-06-13T11:22:25","date_gmt":"2024-06-13T16:22:25","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/"},"modified":"2025-08-29T12:49:19","modified_gmt":"2025-08-29T17:49:19","slug":"participation-rate","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/","title":{"rendered":"Taux de participation"},"content":{"rendered":"<p>Le taux de la participation permet de conna\u00eetre le pourcentage de personnes admissibles au d\u00e9pistage du cancer du sein qui ont effectivement subi un d\u00e9pistage, en conformit\u00e9 avec les lignes directrices. Les facteurs se r\u00e9percutant sur le taux de participation comprennent\u202f: la disponibilit\u00e9 d\u2019un d\u00e9pistage syst\u00e9matique par mammographie ou d\u2019un d\u00e9pistage opportuniste; l\u2019acceptabilit\u00e9, l\u2019accessibilit\u00e9 et la promotion des programmes de d\u00e9pistage; et les strat\u00e9gies de recrutement. Les provinces et les territoires utilisent diverses s<a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-screening-canada-2023-2024\/programs\/\">trat\u00e9gies pour recruter des personnes pour participer au d\u00e9pistage<\/a>.<\/p>\n<p><strong>Pourquoi est-ce important?<\/strong> Une participation \u00e9lev\u00e9e aux programmes de d\u00e9pistage du cancer du sein r\u00e9duit non seulement la morbidit\u00e9 et la mortalit\u00e9 par cancer du sein dans la population admissible, mais augmente \u00e9galement l\u2019efficacit\u00e9 des programmes de d\u00e9pistage<sup>1<\/sup>. Cet indicateur nous montre combien de personnes admissibles au d\u00e9pistage du cancer du sein participent effectivement au programme de d\u00e9pistage organis\u00e9.<\/p>\n<p><strong>D\u00e9finition de l\u2019indicateur\u202f<\/strong>: Pourcentage de la population cible ayant subi un d\u00e9pistage du cancer du sein sur une p\u00e9riode de 30\u202fmois<\/p>\n<p><strong>Cible\u202f<\/strong>: \u2265\u202f70\u00a0% de la population cible sur une p\u00e9riode de 30\u202fmois<\/p>\n<p><strong>P\u00e9riode de mesure\u202f<\/strong>:<\/p>\n<ul>\n<li>1<sup>er<\/sup>\u202fjanvier 2018 au 30\u202fjuin 2020<\/li>\n<li>1<sup>er <\/sup>janvier 2020 au 30\u202fjuin 2022<\/li>\n<\/ul>\n<p>Six mois ont \u00e9t\u00e9 ajout\u00e9s \u00e0 chaque p\u00e9riode de d\u00e9pistage standard de deux ans pour accorder un d\u00e9lai de gr\u00e2ce aux personnes participant au programme leur permettant ainsi de mener \u00e0 bien leur cycle de d\u00e9pistage au-del\u00e0 de la date du deuxi\u00e8me anniversaire de leur d\u00e9pistage.<\/p>\n<p><strong>Calcul de l\u2019indicateur <\/strong>:<\/p>\n<ul>\n<li>Num\u00e9rateur\u202f: Nombre de personnes participant au programme ayant subi au moins un d\u00e9pistage du cancer du sein au cours de la p\u00e9riode de mesure<\/li>\n<li>D\u00e9nominateur\u202f: Population cible \u00e2g\u00e9e de\u202f50 \u00e0\u202f74\u202fans \u00e0 la fin de la p\u00e9riode de mesure<\/li>\n<li>Exclusions\u202f:\n<ul>\n<li>Personnes participant au programme ayant d\u00e9j\u00e0 subi une mastectomie bilat\u00e9rale<\/li>\n<li>Diagnostic ant\u00e9rieur de cancer du sein<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><a style=\"font-size: 1.357em;\" name=\"participation-overall\"><\/a><\/p>\n<h3>Participation au d\u00e9pistage du cancer du sein chez les personnes \u00e2g\u00e9es de\u202f50 \u00e0\u202f74\u202fans ayant subi un d\u00e9pistage dans le cadre d\u2019un programme de d\u00e9pistage par mammographie, par territoire de comp\u00e9tence et par p\u00e9riode de d\u00e9pistage\u00a0\u202f\u2013\u00a0 2018-2019 et 2020-2021<\/h3>\n<p><link rel='stylesheet' href='https:\/\/cdnjs.cloudflare.com\/ajax\/libs\/font-awesome\/4.7.0\/css\/font-awesome.min.css'><link rel='stylesheet' href='https:\/\/www.partnershipagainstcancer.ca\/wp-content\/plugins\/cpac-toolbox\/cpac-toolbox.css?v2'><script type='text\/javascript' src='https:\/\/www.partnershipagainstcancer.ca\/wp-content\/plugins\/cpac-toolbox\/cpac-toolbox.js?v2'><\/script><style>\niframe.cpac-dashboard { .statusBar{display:none;}\r\npbi-status-bar{opacity:0.1;background: white;height: 0;}\r\n.backgroundContainer.outspaceContainer{background:#fff!important;} }\n<\/style><div class='cpac-dashboard-container'><iframe allowfullscreen='allowfullscreen' title='cpac-dashboard-eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935' id='dashboard-eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935' src='https:\/\/dashboard.cpacc.ca\/report\/eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9&language=fr-CA' class='cpac-dashboard'  style='width:100%'><\/iframe><\/div><script>\n                    var is_fullreport = 0;\n                    var scrolled = false;\n                    window.addEventListener('message', function(e){\n                            var this_frame = document.getElementById('dashboard-eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935');\n\n\t\t\t            \/\/ Extract token from parent src\n    \t\t\t        var parentToken = this_frame.src.split('\/').pop();\n\t\t\t\tparentToken = parentToken.split('&')[0];\n\n\/\/                            console.log(JSON.stringify(e.data));\n                    \tif (e.data && e.data.hasOwnProperty('cpac_height') && \n                            e.data.hasOwnProperty('iframe_token') && \n                            e.data.iframe_token === parentToken && \n                            e.origin == 'https:\/\/dashboard.cpacc.ca') { \n                            \n                            console.log('cpac-dashboard: resizing iframe height to ' + e.data.cpac_height + ' for id=dashboard-eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935[' + e.origin + ']' );\n\/\/                                this_frame.height = e.data.cpac_height + 'px';\n                            \n                            if(is_fullreport){\n                                this_frame.style.height = e.data.cpac_height + 'px';\n                            }else if(e.data.cpac_height>200 && e.data.cpac_height<1000){\n                                \/\/ if height = 401px then style.height = 410px\n                                \/\/ if height = 373px then style.height = 380px\n                                \/\/ if height = 350px then style.height = 350px\n                                const cpac_height = (parseInt(e.data.cpac_height\/10)+((e.data.cpac_height%10>0)?1:0))*10;\n                                this_frame.style.height = cpac_height + 'px';\n                            }else{\n                                this_frame.style.height = '500px';\n                            }\n                        }\n\n                            if (e.data && e.data.hasOwnProperty('target_element_y') && e.origin == 'https:\/\/dashboard.cpacc.ca' && !scrolled) {\n                                console.log('received element >>>'+e.data.target_element_y);\n                                let targetYFromDoc = 0;\n                                let element = document.getElementById('dashboard-eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935');\n                                while(element){\n                                    targetYFromDoc += parseInt(element.offsetTop - element.scrollTop + element.clientTop);\n                                    element = element.offsetParent;\n                                }\n                                targetYFromDoc += parseInt(e.data.target_element_y?e.data.target_element_y:0);\n                                window.scrollTo({top: targetYFromDoc, behavior: 'smooth'});\n                                scrolled = true;\n                            }\n                        });\n                        var frame_eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935 = document.getElementById('dashboard-eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935');\n                        frame_eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935.onload = function() {\n                            const styleCode = '.statusBar{display:none;}pbi-status-bar{opacity:0.1;background:white;height:0;}.backgroundContainer.outspaceContainer{background:#fff!important;}';\n                            frame_eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935.contentWindow.postMessage({'style':styleCode ,'value':'sendStyle'},'*');\n                            const targetId = 'null';\n                            frame_eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935.contentWindow.postMessage({'targetId':targetId,'value':'requestTargetPosition'},'*');\n                            const selectBoxId = 'null';\n                            const selectBoxValue = '1';\n                            frame_eyJrIjoiMDkyOTgyNDMtY2FjZS00YmQzLThhMDQtZGY1ODE4NmU3N2RkIiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_935.contentWindow.postMessage({'selectBoxId':selectBoxId,'selectBoxValue':selectBoxValue,'value':'requestTargetSelectBoxTrigger'},'*');\n                        };\n                    <\/script><br \/>\n<sub>* La barre orange pour le Qu\u00e9bec indiquant un taux de participation de\u202f59,7\u202f% repr\u00e9sente les donn\u00e9es de\u202f2019-2020, plut\u00f4t que celles de\u202f2020-2021.<\/sub><br \/>\n<a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/data-tables-breast-indicators\/#participation-overall\"><sub>Tableau de donn\u00e9es et note de bas de page <\/sub><\/a><\/p>\n<p>En\u202f2018-2019 et\u202f2020-2021, les taux de participation au d\u00e9pistage dans tous les territoires de comp\u00e9tence \u00e9taient inf\u00e9rieurs \u00e0 la cible canadienne (\u2265\u202f70\u202f%). Les taux de participation en\u202f2018-2019 variaient de\u202f35,0\u202f% \u00e0 Terre-Neuve-et-Labrador \u00e0\u202f65,6\u202f% au Qu\u00e9bec. En comparaison, les taux de participation en\u202f2020-2021 \u00e9taient plus faibles dans la plupart des territoires de comp\u00e9tence, compte tenu de l\u2019incidence de la pand\u00e9mie de COVID-19, avec des taux allant de\u202f28,4\u202f% en Saskatchewan \u00e0\u202f54,9\u202f% en Ontario.<\/p>\n<p><a name=\"participation-age-group\"><\/a><\/p>\n<h3>Participation au d\u00e9pistage du cancer du sein chez les personnes \u00e2g\u00e9es de\u202f50 \u00e0\u202f74\u202fans ayant subi un d\u00e9pistage dans le cadre d\u2019un programme de d\u00e9pistage par mammographie, par territoire de comp\u00e9tence et par groupe d\u2019\u00e2ge\u202f\u2013\u202f2018-2019 et 2020-2021<\/h3>\n<p><link rel='stylesheet' href='https:\/\/cdnjs.cloudflare.com\/ajax\/libs\/font-awesome\/4.7.0\/css\/font-awesome.min.css'><link rel='stylesheet' href='https:\/\/www.partnershipagainstcancer.ca\/wp-content\/plugins\/cpac-toolbox\/cpac-toolbox.css?v2'><script type='text\/javascript' src='https:\/\/www.partnershipagainstcancer.ca\/wp-content\/plugins\/cpac-toolbox\/cpac-toolbox.js?v2'><\/script><style>\niframe.cpac-dashboard { .statusBar{display:none;}\r\npbi-status-bar{opacity:0.1;background: white;height: 0;}\r\n.backgroundContainer.outspaceContainer{background:#fff!important;} }\n<\/style><div class='cpac-dashboard-container'><iframe allowfullscreen='allowfullscreen' title='cpac-dashboard-eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714' id='dashboard-eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714' src='https:\/\/dashboard.cpacc.ca\/report\/eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9&language=fr-CA' class='cpac-dashboard'  style='width:100%'><\/iframe><\/div><script>\n                    var is_fullreport = 0;\n                    var scrolled = false;\n                    window.addEventListener('message', function(e){\n                            var this_frame = document.getElementById('dashboard-eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714');\n\n\t\t\t            \/\/ Extract token from parent src\n    \t\t\t        var parentToken = this_frame.src.split('\/').pop();\n\t\t\t\tparentToken = parentToken.split('&')[0];\n\n\/\/                            console.log(JSON.stringify(e.data));\n                    \tif (e.data && e.data.hasOwnProperty('cpac_height') && \n                            e.data.hasOwnProperty('iframe_token') && \n                            e.data.iframe_token === parentToken && \n                            e.origin == 'https:\/\/dashboard.cpacc.ca') { \n                            \n                            console.log('cpac-dashboard: resizing iframe height to ' + e.data.cpac_height + ' for id=dashboard-eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714[' + e.origin + ']' );\n\/\/                                this_frame.height = e.data.cpac_height + 'px';\n                            \n                            if(is_fullreport){\n                                this_frame.style.height = e.data.cpac_height + 'px';\n                            }else if(e.data.cpac_height>200 && e.data.cpac_height<1000){\n                                \/\/ if height = 401px then style.height = 410px\n                                \/\/ if height = 373px then style.height = 380px\n                                \/\/ if height = 350px then style.height = 350px\n                                const cpac_height = (parseInt(e.data.cpac_height\/10)+((e.data.cpac_height%10>0)?1:0))*10;\n                                this_frame.style.height = cpac_height + 'px';\n                            }else{\n                                this_frame.style.height = '500px';\n                            }\n                        }\n\n                            if (e.data && e.data.hasOwnProperty('target_element_y') && e.origin == 'https:\/\/dashboard.cpacc.ca' && !scrolled) {\n                                console.log('received element >>>'+e.data.target_element_y);\n                                let targetYFromDoc = 0;\n                                let element = document.getElementById('dashboard-eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714');\n                                while(element){\n                                    targetYFromDoc += parseInt(element.offsetTop - element.scrollTop + element.clientTop);\n                                    element = element.offsetParent;\n                                }\n                                targetYFromDoc += parseInt(e.data.target_element_y?e.data.target_element_y:0);\n                                window.scrollTo({top: targetYFromDoc, behavior: 'smooth'});\n                                scrolled = true;\n                            }\n                        });\n                        var frame_eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714 = document.getElementById('dashboard-eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714');\n                        frame_eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714.onload = function() {\n                            const styleCode = '.statusBar{display:none;}pbi-status-bar{opacity:0.1;background:white;height:0;}.backgroundContainer.outspaceContainer{background:#fff!important;}';\n                            frame_eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714.contentWindow.postMessage({'style':styleCode ,'value':'sendStyle'},'*');\n                            const targetId = 'null';\n                            frame_eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714.contentWindow.postMessage({'targetId':targetId,'value':'requestTargetPosition'},'*');\n                            const selectBoxId = 'null';\n                            const selectBoxValue = '1';\n                            frame_eyJrIjoiNTM3OGU5M2YtZDk1MS00NmU4LTkxMmUtNDU1YjRkNTkxZDQ3IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_714.contentWindow.postMessage({'selectBoxId':selectBoxId,'selectBoxValue':selectBoxValue,'value':'requestTargetSelectBoxTrigger'},'*');\n                        };\n                    <\/script><br \/>\n<a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/data-tables-breast-indicators\/#participation-age-group\"><sub>Tableau de donn\u00e9es et note de bas de page <\/sub><\/a><\/p>\n<p>Dans la plupart des territoires de comp\u00e9tence, les taux de participation ont l\u00e9g\u00e8rement diminu\u00e9 (se sont d\u00e9grad\u00e9s), dans tous les groupes d\u2019\u00e2ge, en\u202f2020-2021 par rapport \u00e0\u202f2018-2019. Dans les Territoires du Nord-Ouest, cependant, les taux de participation en\u202f2020-2021 ont augment\u00e9 dans le groupe d\u2019\u00e2ge des 60 \u00e0\u202f69\u202fans (de\u202f40\u202f% \u00e0\u202f58\u202f%) et dans celui des 70 \u00e0\u202f74\u202fans (de\u202f29,6\u202f% \u00e0\u202f54,5\u202f%). Dans tous les territoires de comp\u00e9tence, le groupe d\u2019\u00e2ge des 60 \u00e0\u202f69\u202fans a enregistr\u00e9 les taux de participation les plus \u00e9lev\u00e9s en\u202f2020-2021.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le taux de la participation permet de conna\u00eetre le pourcentage de personnes admissibles au d\u00e9pistage du cancer du sein qui ont effectivement subi un d\u00e9pistage, en conformit\u00e9 avec les lignes directrices. Les facteurs se r\u00e9percutant sur le taux de participation comprennent\u202f: la disponibilit\u00e9 d\u2019un d\u00e9pistage syst\u00e9matique par mammographie ou d\u2019un d\u00e9pistage opportuniste; l\u2019acceptabilit\u00e9, l\u2019accessibilit\u00e9 et [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":68910,"menu_order":1,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[],"cancer-system-measurement":[],"dbt-cancer-site":[],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-68921","topics","type-topics","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taux de participation - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Le taux de la participation permet de conna\u00eetre le pourcentage de personnes admissibles au d\u00e9pistage du cancer du sein qui ont effectivement subi un d\u00e9pistage, en conformit\u00e9 avec les lignes directrices. Les facteurs se r\u00e9percutant sur le taux de participation comprennent\u202f: la disponibilit\u00e9 d\u2019un d\u00e9pistage syst\u00e9matique par mammographie ou d\u2019un d\u00e9pistage opportuniste; l\u2019acceptabilit\u00e9, l\u2019accessibilit\u00e9 et [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-29T17:49:19+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/participation-rate\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/participation-rate\\\/\",\"name\":\"Taux de participation - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2024-06-13T16:22:25+00:00\",\"dateModified\":\"2025-08-29T17:49:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/participation-rate\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/participation-rate\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/participation-rate\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer du sein\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Indicateurs\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Taux de participation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/","og_locale":"fr_FR","og_type":"article","og_title":"Taux de participation - Canadian Partnership Against Cancer","og_description":"Le taux de la participation permet de conna\u00eetre le pourcentage de personnes admissibles au d\u00e9pistage du cancer du sein qui ont effectivement subi un d\u00e9pistage, en conformit\u00e9 avec les lignes directrices. Les facteurs se r\u00e9percutant sur le taux de participation comprennent\u202f: la disponibilit\u00e9 d\u2019un d\u00e9pistage syst\u00e9matique par mammographie ou d\u2019un d\u00e9pistage opportuniste; l\u2019acceptabilit\u00e9, l\u2019accessibilit\u00e9 et [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2025-08-29T17:49:19+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/","name":"Taux de participation - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2024-06-13T16:22:25+00:00","dateModified":"2025-08-29T17:49:19+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/participation-rate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer du sein","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/"},{"@type":"ListItem","position":3,"name":"Indicateurs","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/"},{"@type":"ListItem","position":4,"name":"Taux de participation"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/68921","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"up":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/68910"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=68921"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=68921"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=68921"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=68921"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=68921"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=68921"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=68921"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=68921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}